Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hamilton Puts the Accuracy and Precision of its Automated Liquid Handling Systems in the Hands of Laboratory Technicians

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
Hamilton Company’s Laboratory and Sensor Products Division introduces the Microlab 300 Series Pipettor, the industry’s first guided pipetting system.

The product is designed to bring the assurance of an automated liquid handling system into the hands of the laboratory technician at a low cost and without complex programming. This lightweight, hand-held device enables laboratories to achieve unsurpassed quality assurance through reproducible and traceable methods, and to reduce sample preparation time by eliminating inefficient steps.

“The innovative design of the Microlab 300 Series Pipettor replaces three to four manual or electronic pipettes with one device. Users can dispense between 0.5–1000 µL without needing to exchange pipettes,” says Jason March, Marketing Director of the Laboratory and Sensor Products Division. “The Microlab 300 achieves this range with just one probe and two tip sizes, instead of the three pipette sizes and three tip sizes typically required.”

The Microlab 300 meets GLP/GMP, RoHS, 21 CFR Part 11, and ISO-8655 regulations. The system also exceeds accuracy benchmarks set by the industry by allowing users to fine-tune pipetting parameters for each liquid.

“One of the core benefits of the Microlab 300 is its ability to improve pipetting accuracy through standard and customizable Liquid Classes,” says Devon Bateman, Product Manager for Hamilton Company. “Technicians can establish pipetting speeds and delays easily for any fluid, giving them the power to successfully pipette the most challenging liquids.”

The Microlab 300 is also unique because of its user-friendly, proprietary software. The system goes beyond pre-programmed pipetting operations for common techniques, like reverse pipetting and aliquoting, and allows technicians to easily create, save, and execute pipetting applications from start to finish. Users also benefit from a range of software advancements:

•    Linked Methods serve as electronic standard operating procedures and eliminate process errors by guiding the technician graphically through the pipetting steps in a controlled and auditable manner.
•    Sample volumes are automatically set by the system, eliminating manual adjustment errors.
•    Log files of all pipetting activities are generated and stored for traceability.
•    User accounts and password protection provide additional system security and accountability.

The Microlab 300 is currently available in North and South America, Australia and the Pacific Rim.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!